دورية أكاديمية
ATP released from dying cancer cells stimulates P2X4 receptors and mTOR in their neighbors.
| العنوان: | ATP released from dying cancer cells stimulates P2X4 receptors and mTOR in their neighbors. |
|---|---|
| المؤلفون: | Suzuki-Kerr H; Department of Physiology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Building 502-401, 85 Park Road, Grafton, Auckland, 1023, New Zealand. h.suzuki-kerr@auckland.ac.nz.; Eisdell Moore Centre, University of Auckland, Auckland, New Zealand. h.suzuki-kerr@auckland.ac.nz.; Aotearoa Brain Project - Kaupapa Roro o Aotearoa, Dunedin, New Zealand. h.suzuki-kerr@auckland.ac.nz. |
| المصدر: | Purinergic signalling [Purinergic Signal] 2024 Feb; Vol. 20 (1), pp. 1-4. Date of Electronic Publication: 2023 Feb 08. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't; Comment |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101250499 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-9546 (Electronic) Linking ISSN: 15739538 NLM ISO Abbreviation: Purinergic Signal Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Dordrecht, the Netherlands : Springer |
| مواضيع طبية MeSH: | Receptors, Purinergic P2X4* , Neoplasms*, Cells, Cultured ; TOR Serine-Threonine Kinases ; Adenosine Triphosphate ; Receptors, Purinergic P2X7 |
| التعليقات: | Comment on: Nature. 2022 Dec;612(7939):347-353. doi: 10.1038/s41586-022-05426-1. (PMID: 36385525) |
| References: | Physiol Rev. 2021 Jul 1;101(3):1371-1426. (PMID: 33599151) Biochem Pharmacol. 2021 May;187:114385. (PMID: 33359010) Front Pharmacol. 2017 Nov 22;8:860. (PMID: 29213241) Mol Pharmacol. 2006 Feb;69(2):576-87. (PMID: 16282518) Biochem Biophys Res Commun. 2015 Nov 20;467(3):484-90. (PMID: 26456657) Front Cell Dev Biol. 2021 Jun 17;9:695041. (PMID: 34222263) Curr Opin Pharmacol. 2019 Aug;47:126-132. (PMID: 31039505) Cell Death Discov. 2021 Nov 10;7(1):346. (PMID: 34759265) Front Immunol. 2021 Mar 25;12:645834. (PMID: 33897694) J Physiol. 2018 Oct;596(20):4893-4907. (PMID: 30144063) Nature. 2011 Sep 18;478(7368):255-9. (PMID: 21927002) Int J Biochem Cell Biol. 2013 May;45(5):932-43. (PMID: 23434541) Exp Eye Res. 2008 May;86(5):844-55. (PMID: 18407266) PLoS One. 2013;8(4):e60184. (PMID: 23565201) Nature. 2022 Dec;612(7939):347-353. (PMID: 36385525) J Neurosci. 2002 Jun 15;22(12):4814-24. (PMID: 12077178) Oncogene. 2022 May;41(21):2920-2931. (PMID: 35411034) Int Rev Cell Mol Biol. 2015;320:41-73. (PMID: 26614871) J Biol Chem. 2014 Jun 20;289(25):17658-67. (PMID: 24817123) J Cell Biol. 2015 Jun 22;209(6):879-94. (PMID: 26101220) FEBS Open Bio. 2022 Apr;12(4):739-757. (PMID: 34878722) Cell. 2017 Mar 9;168(6):960-976. (PMID: 28283069) J Pathol. 2022 Feb;256(2):149-163. (PMID: 34652816) Physiol Rev. 2002 Oct;82(4):1013-67. (PMID: 12270951) Int J Cancer. 2019 Aug 15;145(4):1068-1082. (PMID: 30761524) Purinergic Signal. 2023 Mar;19(1):255-263. (PMID: 35771310) J Gen Physiol. 2018 Feb 5;150(2):277-291. (PMID: 29282210) |
| المشرفين على المادة: | 0 (Receptors, Purinergic P2X4) EC 2.7.11.1 (TOR Serine-Threonine Kinases) 8L70Q75FXE (Adenosine Triphosphate) 0 (Receptors, Purinergic P2X7) |
| تواريخ الأحداث: | Date Created: 20230207 Date Completed: 20240201 Latest Revision: 20240727 |
| رمز التحديث: | 20240728 |
| مُعرف محوري في PubMed: | PMC10828246 |
| DOI: | 10.1007/s11302-023-09926-1 |
| PMID: | 36750529 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1573-9546 |
|---|---|
| DOI: | 10.1007/s11302-023-09926-1 |